Fibrogen Stock Price History

FGEN Stock

USD 0.39 0.01 2.50%

Below is the normalized historical share price chart for FibroGen extending back to November 14, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of FibroGen stands at 0.39, as last reported on the 28th of November, with the highest price reaching 0.39 and the lowest price hitting 0.38 during the day.

IPO Date

14th of November 2014

200 Day MA

0.9864

50 Day MA

0.3567

Beta

0.726

Yuan Drop

Covid

If you're considering investing in FibroGen Stock, it is important to understand the factors that can impact its price. FibroGen appears to be abnormally volatile, given 3 months investment horizon. FibroGen secures Sharpe Ratio (or Efficiency) of 0.0443, which denotes the company had a 0.0443% return per unit of standard deviation over the last 3 months. We have found twenty-eight technical indicators for FibroGen, which you can use to evaluate the volatility of the firm. Please utilize FibroGen's Semi Deviation of 5.45, downside deviation of 6.97, and Mean Deviation of 4.76 to check if our risk estimates are consistent with your expectations.

At this time, FibroGen's Liabilities And Stockholders Equity is very stable compared to the past year. As of the 28th of November 2024, Capital Stock is likely to grow to about 1 M, though Total Stockholder Equity is likely to grow to (194 M). . As of the 28th of November 2024, Price To Sales Ratio is likely to drop to 0.55. In addition to that, Price Earnings Ratio is likely to drop to -0.32. FibroGen Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0443

Best Portfolio	Best Equity
Good Returns
Average Returns
Small Returns			FGEN
Cash	Small Risk	Average Risk	High Risk	Huge Risk
Negative Returns

Estimated Market Risk

6.52

actual daily

58% of assets are less volatile

Expected Return

0.29

actual daily

95% of assets have higher returns

Risk-Adjusted Return

0.04

actual daily

97% of assets perform better

Based on monthly moving average FibroGen is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of FibroGen by adding it to a well-diversified portfolio.

Price Book

53.8258

Enterprise Value Ebitda

(0.17)

Price Sales

0.2255

Shares Float

90.5 M

Wall Street Target Price

0.6

FibroGen Stock Price History Chart

There are several ways to analyze FibroGen Stock price data. The simplest method is using a basic FibroGen candlestick price chart, which shows FibroGen price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

Highest Price	September 13, 2024	0.47
Lowest Price	October 28, 2024	0.3

FibroGen November 28, 2024 Stock Price Synopsis

Various analyses of FibroGen's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell FibroGen Stock. It can be used to describe the percentage change in the price of FibroGen from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of FibroGen Stock.

	FibroGen Price Rate Of Daily Change	0.98
	FibroGen Price Daily Balance Of Power	(1.00)

FibroGen November 28, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in FibroGen Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use FibroGen intraday prices and daily technical indicators to check the level of noise trading in FibroGen Stock and then apply it to test your longer-term investment strategies against FibroGen.

FibroGen Stock Price History Data

The price series of FibroGen for the period between Fri, Aug 30, 2024 and Thu, Nov 28, 2024 has a statistical range of 0.17 with a coefficient of variation of 10.91. Under current investment horizon, the daily prices are spread out with arithmetic mean of 0.37. The median price for the last 90 days is 0.37. The company completed 1:1 stock split on September 8, 2009.

	Open	High	Low	Close	Volume
11/28/2024	0.38	0.39	0.38	0.39
11/27/2024	0.38	0.39	0.38	0.39	428,901
11/26/2024	0.40	0.40	0.38	0.39	368,395
11/25/2024	0.40	0.40	0.38	0.39	996,683
11/22/2024	0.38	0.40	0.38	0.40	1,270,050
11/21/2024	0.34	0.39	0.34	0.39	1,328,395
11/20/2024	0.36	0.36	0.34	0.35	1,294,568
11/19/2024	0.34	0.35	0.33	0.35	1,173,184
11/18/2024	0.35	0.35	0.33	0.34	967,431
11/15/2024	0.37	0.39	0.33	0.33	1,794,085
11/14/2024	0.33	0.39	0.33	0.37	1,963,292
11/13/2024	0.41	0.42	0.18	0.33	3,945,817
11/12/2024	0.34	0.40	0.33	0.39	3,637,304
11/11/2024	0.32	0.36	0.32	0.34	1,742,947
11/08/2024	0.31	0.33	0.31	0.32	943,413
11/07/2024	0.31	0.33	0.30	0.31	996,044
11/06/2024	0.30	0.32	0.30	0.31	813,244
11/05/2024	0.33	0.33	0.30	0.31	1,156,757
11/04/2024	0.32	0.33	0.32	0.33	485,084
11/01/2024	0.30	0.34	0.30	0.32	769,317
10/31/2024	0.31	0.32	0.29	0.30	1,207,549
10/30/2024	0.31	0.33	0.30	0.32	1,154,007
10/29/2024	0.31	0.31	0.30	0.31	1,342,370
10/28/2024	0.31	0.33	0.30	0.30	2,221,614
10/25/2024	0.32	0.34	0.30	0.31	2,751,854
10/24/2024	0.33	0.34	0.32	0.32	1,617,317
10/23/2024	0.35	0.36	0.32	0.32	1,214,484
10/22/2024	0.37	0.38	0.35	0.35	1,206,326
10/21/2024	0.40	0.40	0.36	0.37	1,171,397
10/18/2024	0.40	0.40	0.38	0.39	862,411
10/17/2024	0.38	0.40	0.37	0.40	2,711,563
10/16/2024	0.35	0.38	0.35	0.38	426,789
10/15/2024	0.35	0.38	0.34	0.35	1,369,125
10/14/2024	0.36	0.36	0.34	0.34	866,342
10/11/2024	0.34	0.36	0.34	0.36	830,678
10/10/2024	0.33	0.34	0.31	0.34	1,215,971
10/09/2024	0.34	0.34	0.30	0.33	1,408,871
10/08/2024	0.35	0.35	0.31	0.33	2,541,455
10/07/2024	0.38	0.39	0.34	0.34	2,171,395
10/04/2024	0.38	0.40	0.36	0.37	914,645
10/03/2024	0.40	0.40	0.39	0.40	410,313
10/02/2024	0.39	0.40	0.37	0.40	582,908
10/01/2024	0.39	0.41	0.38	0.39	407,726
09/30/2024	0.41	0.43	0.39	0.40	1,098,088
09/27/2024	0.38	0.41	0.38	0.41	462,868
09/26/2024	0.37	0.39	0.37	0.39	333,998
09/25/2024	0.38	0.39	0.37	0.37	328,966
09/24/2024	0.37	0.40	0.36	0.38	571,067
09/23/2024	0.39	0.40	0.36	0.37	809,049
09/20/2024	0.43	0.43	0.38	0.41	1,575,850
09/19/2024	0.42	0.44	0.41	0.42	601,029
09/18/2024	0.44	0.46	0.41	0.42	903,284
09/17/2024	0.45	0.47	0.44	0.45	413,684
09/16/2024	0.47	0.49	0.45	0.45	900,306
09/13/2024	0.42	0.48	0.42	0.47	1,059,123
09/12/2024	0.40	0.43	0.40	0.42	1,245,310
09/11/2024	0.40	0.41	0.38	0.40	407,762
09/10/2024	0.40	0.42	0.37	0.40	1,476,965
09/09/2024	0.40	0.42	0.38	0.39	446,497
09/06/2024	0.42	0.43	0.38	0.39	892,818
09/05/2024	0.39	0.43	0.38	0.43	1,503,998

About FibroGen Stock history

FibroGen investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for FibroGen is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in FibroGen will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing FibroGen stock prices may prove useful in developing a viable investing in FibroGen

	Last Reported	Projected for Next Year
Common Stock Shares Outstanding	97.3 M	78.2 M
Net Loss	-264.3 M	-251.1 M

FibroGen Quarterly Net Working Capital

60.87 Million

FibroGen Stock Technical Analysis

FibroGen technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.

Volatility Indicators

View

Value Movement

View

A focus of FibroGen technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of FibroGen trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Portfolio Dashboard Now

Portfolio Dashboard

Portfolio dashboard that provides centralized access to all your investments

All Next

Launch Module

FibroGen Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for FibroGen's price direction in advance. Along with the technical and fundamental analysis of FibroGen Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of FibroGen to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

	Risk Adjusted Performance	0.0328
	Jensen Alpha	(0.01)
	Total Risk Alpha	(0.78)
	Sortino Ratio	0.011
	Treynor Ratio	0.1084

	Cycle Indicators
	Math Operators
	Math Transform
	Momentum Indicators
	Overlap Studies
	Pattern Recognition
	Price Transform
	Statistic Functions
	Volatility Indicators
	Volume Indicators

When determining whether FibroGen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of FibroGen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Fibrogen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Fibrogen Stock:

How To Invest In FibroGen

Details

Is FibroGen Stock a good investment?

Details

What is FibroGen's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in FibroGen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

To learn how to invest in FibroGen Stock, please use our How to Invest in FibroGen guide.

You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of FibroGen. If investors know FibroGen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about FibroGen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.536

Earnings Share

(1.23)

Revenue Per Share

1.758

Quarterly Revenue Growth

0.143

Return On Assets

(0.27)

The market value of FibroGen is measured differently than its book value, which is the value of FibroGen that is recorded on the company's balance sheet. Investors also form their own opinion of FibroGen's value that differs from its market value or its book value, called intrinsic value, which is FibroGen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because FibroGen's market value can be influenced by many factors that don't directly affect FibroGen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between FibroGen's value and its price as these two are different measures arrived at by different means. Investors typically determine if FibroGen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, FibroGen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Fibrogen Stock Price History

Sharpe Ratio = 0.0443

Estimated Market Risk

Expected Return

Risk-Adjusted Return

FibroGen Stock Price History Chart

FibroGen November 28, 2024 Stock Price Synopsis

FibroGen November 28, 2024 Stock Price Analysis

FibroGen Stock Price History Data

About FibroGen Stock history

FibroGen Quarterly Net Working Capital

60.87 Million

FibroGen Stock Technical Analysis

Did you try this?

Run Portfolio Dashboard Now

Portfolio Dashboard

FibroGen Technical and Predictive Indicators

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY